IceCure Medical Extends $13.96M At-The-Market Offering Program

summarizeSummary

IceCure Medical Ltd. has extended its At-The-Market (ATM) equity distribution agreement, allowing it to continue offering up to $13.96 million in ordinary shares until March 13, 2026.

check_boxKey Events

• ATM Program Extended

  IceCure Medical Ltd. entered into an amendment to its Equity Distribution Agreement with Maxim Group LLC, extending the period for its At-The-Market (ATM) offering program.

• Significant Potential Dilution Maintained

  The company can continue to offer and sell up to $13,960,500 of its ordinary shares, representing a substantial potential dilution relative to its current market capitalization.

• New Termination Date

  The agreement's termination date has been extended from January 13, 2026, to March 13, 2026, prolonging the period of potential share sales.

auto_awesomeAnalysis

IceCure Medical Ltd. has extended the period during which it can sell a substantial amount of its ordinary shares through an At-The-Market (ATM) offering. This extension prolongs the potential for significant dilution, as the company can still offer up to $13.96 million in shares, which represents a considerable portion of its current market capitalization. Investors should monitor the actual utilization of this program, as continuous share sales could exert downward pressure on the stock price.